These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy. Wells WG, Woods GL, Jiang Q, Gesser RM. J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185 [Abstract] [Full Text] [Related]
29. Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia. Pertel PE, Bernardo P, Fogarty C, Matthews P, Northland R, Benvenuto M, Thorne GM, Luperchio SA, Arbeit RD, Alder J. Clin Infect Dis; 2008 Apr 15; 46(8):1142-51. PubMed ID: 18444848 [Abstract] [Full Text] [Related]
30. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections. Bjornson HS, Ramirez-Ronda C, Saavedra S, Rivera-Vázquez CR, Liu C, Hinthorn DR. Clin Ther; 1993 Apr 15; 15(1):65-78. PubMed ID: 8458056 [Abstract] [Full Text] [Related]
31. [Use of ceftriaxone in urinary and respiratory tract infections]. Papierkowski A, Pietraszek-Mamcarz J, Kozłowska T, Górnicka G, Emeryk A. Pol Tyg Lek; 1993 Apr 15; 45(14-15):300-2. PubMed ID: 2235713 [Abstract] [Full Text] [Related]
33. [Clinical and pharmacokinetic study of ceftriaxone in severe infections in adults in intensive care]. Albanèse J, Saux P, Martin C, Mallet MN, Charrel J, de Micco P, Gouin F. Pathol Biol (Paris); 1986 May 15; 34(5):457-60. PubMed ID: 3534721 [Abstract] [Full Text] [Related]
34. [Bronchial diffusion of ceftriaxone]. Husson MO, Debout J, Krivosic-Horber R. Pathol Biol (Paris); 1986 May 15; 34(5):325-7. PubMed ID: 3534699 [Abstract] [Full Text] [Related]
35. Single daily dose treatment of severe refractory infections with ceftriaxone. Cost savings and possible parenteral outpatient treatment. Baumgartner JD, Glauser MP. Arch Intern Med; 1983 Oct 15; 143(10):1868-73. PubMed ID: 6312914 [Abstract] [Full Text] [Related]
36. Clinical assessment of sulbenicillin in acute respiratory tract infection. Macchioni PL, Del Din G, Filippi G, Baricchi R, Bertani A, Portioli I. Drugs Exp Clin Res; 1985 Oct 15; 11(12):879-83. PubMed ID: 3836118 [Abstract] [Full Text] [Related]
37. [The French experience with moxalactam in pneumology]. Leng B, Imbert Y, Coomans D. Sem Hop; 1983 Jun 30; 59(26):1977-80. PubMed ID: 6310790 [Abstract] [Full Text] [Related]
38. Intravenous fleroxacin versus ceftazidime in the treatment of acute nonpneumococcal lower respiratory tract infections. Farkas SA. Am J Med; 1993 Mar 22; 94(3A):142S-149S. PubMed ID: 8452171 [Abstract] [Full Text] [Related]
39. Acute bronchopulmonary infections: treatment with i.v. spiramycin. Vachon F, Kernbaum S. Chemioterapia; 1987 Aug 22; 6(4):282-5. PubMed ID: 3308147 [Abstract] [Full Text] [Related]
40. Comparison of netilmicin with ceftriaxone for the treatment of severe or complicated urinary tract infections. Bailey RR, Lynn KL, Peddie BA, Walker RJ, Swainson CP. N Z Med J; 1986 Jun 25; 99(804):459-61. PubMed ID: 3526208 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]